Eunkyeong Jung
Overview
Explore the profile of Eunkyeong Jung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jung E, Mao C, Bhatia M, Koellhoffer E, Fiering S, Steinmetz N
Mol Pharm
. 2022 Nov;
20(1):500-507.
PMID: 36399598
Cowpea mosaic virus (CPMV) has been developed as a promising nanoplatform technology for cancer immunotherapy; when applied as in situ vaccine, CPMV exhibits potent, systemic, and durable efficacy. While CPMV...
12.
Song N, Park M, Kim N, Lee Y, Jung E, Lee D
Biomater Sci
. 2022 Oct;
10(21):6160-6171.
PMID: 36222413
Compared to normal cells, cancer cells are more susceptible to insults of prooxidants that generate ROS (reactive oxygen species) or scavenge antioxidants such as glutathione (GSH). Cancer cells undergo immunogenic...
13.
Oxidative Stress Amplifying Polyprodrug Micelles as Drug Carriers for Combination Anticancer Therapy
Lee Y, Song N, Kim N, Yang M, Kwon G, Hyeon H, et al.
Biomacromolecules
. 2022 Aug;
23(9):3887-3898.
PMID: 36007196
Cancer cells are more vulnerable to reactive oxygen species (ROS)-mediated oxidative stress than normal cells due to disturbed redox balance. It can be postulated that ROS-generating drug carriers exert anticancer...
14.
Jung E, Jeong S, Lee Y, Jeon C, Shin H, Song N, et al.
Biomaterials
. 2022 Aug;
287:121681.
PMID: 35917709
Stimulus-responsive self-assembling prodrug-based nanomedicine has emerged as a novel paradigm in controlled drug delivery. All-trans retinoic acid (RA), one of vitamin A metabolites, induces apoptotic cancer cell death, but its...
15.
Jung E, Song N, Lee Y, Kwon G, Kwon S, Lee D
Biomaterials
. 2022 Apr;
284:121515.
PMID: 35429813
Self-assembling prodrugs are able to form stable nanoparticles without additional excipients and therefore have gained increasing interest in the field of drug delivery. As a natural derivative of vitamin A,...
16.
Hong S, Lee Y, Shin H, Kim T, Jung E, Lee D
ACS Appl Bio Mater
. 2022 Jan;
4(4):3145-3154.
PMID: 35014402
Ischemia/reperfusion (IR) injury is induced by the restoration of blood flow to the prolonged ischemic tissues and is considered as the paradoxical exacerbation of ischemic damages. A large amount of...
17.
Han S, Lee J, Jung E, Park S, Sagawa A, Shibasaki Y, et al.
ACS Appl Bio Mater
. 2022 Jan;
4(3):2465-2474.
PMID: 35014365
Prodrug-type polymer-drug conjugates based on highly biocompatible functional polyethers are developed through mechanochemical post-polymerization modification. Herein, we design functional epoxide monomers of ethoxyethyl glycidyl ether (EEGE) and azidohexyl glycidyl ether...
18.
Jung E, Lee J, Lee Y, Seon S, Park M, Song C, et al.
ACS Appl Bio Mater
. 2022 Jan;
4(5):4450-4461.
PMID: 35006857
Phototherapy including photothermal therapy (PTT) and photodynamic therapy (PDT) uses photosensitizers and light to kill cancer cells and has become a promising therapeutic modality because of advantages such as minimal...
19.
Lee H, Jeong S, Jung E, Lee D
Nanomedicine
. 2020 Sep;
30:102301.
PMID: 32942045
Asthma is a common airway inflammatory disorder, characterized by increased infiltration of leukocytes and bronchoconstriction. Dexamethasone (DEX) has been widely used in the treatment of allergic asthma. However, long-term and...
20.
Hong E, Hyun H, Lee H, Jung E, Lee D
Int J Pharm
. 2019 Nov;
574:118893.
PMID: 31765773
Combination therapy, a treatment regimen that combines more than two therapeutic agents to diseased tissues has recently gained increasing attentions in anticancer therapy. As cancer cells are more vulnerable to...